Viking Therapeutics
VKTX
66 hedge funds and large institutions have $91.4M invested in Viking Therapeutics in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.
825% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 4
249% more call options, than puts
Call options by funds: $747K | Put options by funds: $214K
141% more capital invested
Capital invested by funds: $37.9M → $91.4M (+$53.4M)
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
100% more funds holding
Funds holding: 33 → 66 (+33)
22.72% more ownership
Funds ownership: 18.35% → 41.07% (+23%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$17.6M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.2M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.01M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$4.15M |
| 5 |
Millennium Management
New York
|
+$3.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.06M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$1.43M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$553K |
| 4 |
Renaissance Technologies
New York
|
-$392K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$351K |
VKTX Hedge Fund Activity: Q1 2018 in Review
66 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2018, worth a combined $91.4M — up 141% from $37.9M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new VKTX positions and 4 closed out — a net gain of 33 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $17.6M. The largest seller was Sphera Funds Management, cutting an estimated $3.06M.
- 66 institutional investors held Viking Therapeutics (VKTX) as of Q1 2018, up from 33 in Q4 2017.
- Funds reported $91.4M of Viking Therapeutics stock for Q1 2018, up 141% quarter-over-quarter.
- 37 funds opened new Viking Therapeutics positions in Q1 2018 and 4 closed out, a net change of +33 holders.
- The largest Viking Therapeutics buyer in Q1 2018 was Boxer Capital, an estimated $17.6M added.
- The largest Viking Therapeutics seller in Q1 2018 was Sphera Funds Management, an estimated $3.06M sold.
Based on aggregated 13F filings for Q1 2018.